Aetna plans to sell Medicare Advantage drug plans in 41 states plus Washington, D.C. for 2027, reaching 57 million Medicare-eligible people, and to bring its chronic-condition special needs plans to six more states, for 25 in all. The same announcement carries a condition for people who join one of those chronic-condition plans: if Aetna does not receive verification of the qualifying condition, the member is disenrolled.
Aetna’s Oct. 3 2027 Medicare release, issued through its parent company CVS Health, puts it in one sentence: “If verification of eligible condition is not received, involuntary disenrollment will occur.” Jeff Fernandez, president of Aetna Medicare, said in the release that “the right Medicare coverage protects your health and your peace of mind.”
How a chronic-condition plan works
A chronic-condition special needs plan, or C-SNP, is a Medicare Advantage plan limited to people with specific long-term illnesses. Aetna names diabetes mellitus, chronic heart failure and certain cardiovascular disorders. Joining requires at least one qualifying condition, and Aetna says it will confirm that condition with the member’s provider as part of enrolling.
That makes the first job for a C-SNP applicant a paperwork one. The condition has to be on record with a doctor who answers Aetna’s request, and the release attaches a consequence to a verification that never arrives. It gives no deadline for the verification and does not say what the member’s coverage becomes if disenrollment happens.
A member removed from a chronic-condition plan for missing paperwork still has to land in a plan that covers the right drugs and doctors, and Medicare’s Annual Enrollment Period closes Dec. 7. Inside The 2027 Medicare Open Enrollment Decision Kit, a cost calculator spreadsheet that compares plans on cost, drugs and doctors puts each option side by side.
Price a back-up plan before a C-SNP verification can fail, with the Decision Kit calculator →
Six new states, none named
Aetna says the expansion brings C-SNP availability to a total of 25 states. The release does not list the six new ones, so whether a plan is sold in a particular county is a question for Medicare’s plan comparison tool once the 2027 plans are posted.
The wider footprint is the Medicare Advantage drug plans, sold in 41 states plus D.C. Aetna also sells Medicare Advantage plans without drug coverage, a stand-alone drug plan called SilverScript Choice, and Medicare Supplement policies. The release describes expansions only and mentions no plan exits.
What the chronic-condition plans add
C-SNPs carry $0 copays for primary care and for certain specialist visits tied to the covered condition, according to Aetna. Members of C-SNPs and of dual-eligible special needs plans get a monthly allowance for certain over-the-counter products on the Aetna Medicare Extra Benefits Card, which runs on CVS Flex Benefits. Members with qualifying chronic conditions can also use the card for groceries, personal care, transportation and utilities.
Those extras are what the verification step protects, and what a disenrolled member would lose. They are also Aetna’s description of its own plans, and the release lists them for select plans rather than every plan.
What the $0 copay figures count
Aetna says 97 percent of its Medicare Advantage drug plans have a $0 copay for primary care visits and 70 percent have $0 lab copays. Both are shares of plans, not shares of members, so they do not say how many people actually pay nothing. The release adds that every county has at least one $0-premium plan and that all plans have $0 Tier 1 drug copays at preferred pharmacies.
The wider market is narrowing too. A KFF analysis published Oct. 1 found the average beneficiary can choose from 28 Medicare Advantage drug plans for 2027, down from 32 in 2026.
Verifying a condition and comparing plans before Dec. 7
The Annual Enrollment Period runs Oct. 15 through Dec. 7, 2026, as Aetna’s release states. Medicare’s free Plan Finder lists the plans sold in a given area, including the C-SNPs and the ordinary Medicare Advantage and Part D options beside them.
For a C-SNP applicant, the practical record is a short one: the diagnosis the doctor has on file, the date the doctor’s office was asked to confirm it, and who at the office handled the request. Aetna lists 1-844-588-0041 (TTY 711), open 7 days a week from 8 a.m. to 8 p.m., for questions about its plans, and 1-800-MEDICARE for complaints about Medicare coverage.
Pricing a second plan while the first is still pending costs nothing. If verification comes through, the comparison confirms the choice. If it does not, the work is done before the Dec. 7 close.
A chronic-condition plan can end without verification
The stake is a gap: a plan that ends over missing proof of a condition leaves the member choosing fast, with their drugs and doctors still to match. The 2027 Medicare Open Enrollment Decision Kit covers the comparison half of that job, with a cost calculator spreadsheet and the Open Enrollment calendar for the Oct. 15 to Dec. 7 window. The verification itself stays between the member, the doctor and Aetna.
Line up a replacement plan before Dec. 7 with the Decision Kit calculator and calendar →
This article was produced with AI assistance and edited for accuracy against the sources linked above.
